PEMBROKE, Bermuda--(BUSINESS WIRE)-- AXIS Capital Holdings Limited ("AXIS Capital" or the "Company") (NYSE: AXS) today announced the publication of the Company's 2022 Loss Development Triangles. A ...
Pedestrians walk by the Pfizer corporate headquarters in New York City (2020). On Monday the company said it was discontinuing development of a weight-loss drug in pill form. File Photo by John ...
Pfizer announced on Monday that it is halting development of its oral weight-loss pill after one patient experienced liver issues. The company said it halted development of danuglipron, an oral drug ...
PEMBROKE, Bermuda--(BUSINESS WIRE)--Validus Holdings, Ltd. (NYSE:VR) (“Validus”) today announced that it has published its 2017 Loss Development Triangles (the “2017 Triangles”) on its website located ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback